This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
Welcome to BPI Europe 2024!
9-12 April 2024Messe Wien Congress Centre, Vienna

David Kentner
Principal Scientist II at Novartis


David Kentner is a Principal Scientist at the Cell Line Screening and Development (CLSD) unit at the Biologics Research Center (BRC) at Novartis. Before joining Novartis in 2015, David did a PhD at the University of Heidelberg (working on bacterial signaling pathways) and worked as a Postdoc at the Biocenter in Basel (investigating metabolic aspects of infection). In his current role, David manages the whole span of cell line activities, from early research and candidate profiling, to the generation of high producer cell lines for manufacturing, and finally supporting the characterization of cell banks.

Agenda Sessions

  • Meet Market Demand Faster with Higher Grams per Litre